“…The precaution of excluding cross-kingdom sRNAs (ck-sRNAs) helps avoid undesirable effects on non-target species. For this purpose, when preparing samples for the sequencing step, it is necessary to treat samples in order to avoid contamination with other organisms (plant cells, endogenous microbiota, parasites) [50], determine the number of biological replicates and calculate the correct amount of reads to achieve sufficient genome coverage (typically three biological replicates with 5-10 million reads each). Sequencing of sRNAs is carried out using a wide variety of high-throughput technologies [51,52], including MiSeq and HiSeq (Illumina Inc., San Diego, California, EUA), SMRT PacBio (Pacific BioSciences, Menlo Park, California, EUA), and Roche 454 technologies (Branford, Connecticut), depending on the output range and total reads per run required [53].…”